Exploring O
the O
Neuroplastic O
Effects O
of O
Biofeedback O
Training O
on O
Smokers O
Smoking O
and O
stress O
cooccur O
in O
different O
stages O
of O
a O
nicotine O
addiction O
cycle O
, O
affecting O
brain O
function O
and O
showing O
additive O
impact O
on O
different O
physiological O
responses O
. O

Resting-state O
functional O
connectivity O
has O
shown O
potential O
in O
identifying O
these O
alterations O
. O

Nicotine O
addiction O
has O
been O
associated O
with O
detrimental O
effects O
on O
functional O
integrity O
of O
the O
central O
nervous O
system O
, O
including O
the O
organization O
of O
resting-state O
networks O
. O

Prolonged O
stress O
may O
result O
in O
enhanced O
activation O
of O
the O
default O
mode O
network O
( O
DMN O
) O
. O

Considering O
that O
biofeedback O
has O
shown O
promise O
in O
alleviating O
physiological O
manifestations O
of O
stress O
, O
we O
aimed O
to O
explore O
the O
possible O
neuroplastic O
effects O
of O
biofeedback O
training O
on O
smokers O
. O

Clinical O
, O
behavioral O
, O
and O
neurophysiological O
( O
resting-state O
EEG O
) O
data O
were O
collected O
from O
twenty-seven O
subjects O
before O
and O
after O
five O
sessions O
of O
skin O
temperature O
training O
. O

DMN O
functional O
cortical O
connectivity O
was O
investigated O
. O

While O
clinical O
status O
remained O
unaltered O
, O
the O
degree O
of O
nicotine O
dependence O
and O
psychiatric O
symptoms O
were O
significantly O
improved O
. O

Significant O
changes O
in O
DMN O
organization O
and O
network O
properties O
were O
not O
observed O
, O
except O
for O
a O
significant O
increase O
of O
information O
flow O
from O
the O
right O
ventrolateral O
prefrontal O
cortex O
and O
right O
temporal O
pole O
cortex O
towards O
other O
DMN O
components O
. O

Biofeedback O
aiming O
at O
stress O
alleviation O
in O
smokers O
could O
play O
a O
protective O
role O
against O
maladaptive O
plasticity O
of O
connectivity O
. O

Multiple O
sessions O
, O
individualized O
interventions O
and O
more O
suitable O
methods O
to O
promote O
brain O
plasticity O
, O
such O
as O
neurofeedback O
training O
, O
should O
be O
considered O
. O

2 O
. O

Materials O
and O
Methods O
2.1 O
. O

Participants O
We O
recruited O
twenty-seven O
smokers O
( O
male O
: O
female O
, O
9 O
: O
18 O
) O
with O
a O
mean O
age O
of O
50.52 O
years O
( O
range O
: O
24–75 O
, O
standard O
deviation O
( O
SD O
) O
: O
12.364 O
) O
. O

The O
participants O
were O
recruited O
in O
the O
context O
of O
the O
SmokeFreeBrain O
project O
following O
the O
inclusion O
and O
exclusion O
criteria O
of O
the O
neurofeedback O
clinical O
study O
protocol O
( O
https O
: O
//clinicaltrials.gov/ct2/show/NCT02991781 O
) O
. O

All O
subjects O
signed O
an O
informed O
consent O
form O
, O
prior O
to O
their O
inclusion O
, O
in O
compliance O
with O
the O
Code O
of O
Ethics O
of O
the O
World O
Medical O
Association O
( O
Declaration O
of O
Helsinki O
) O
. O

Inclusion O
criteria O
were O
the O
following O
: O
( O
1 O
) O
active O
smokers O
( O
more O
than O
ten O
cigarettes O
per O
day O
) O
, O
( O
2a O
) O
either O
being O
unemployed O
for O
at O
least O
three O
months O
and O
between O
eighteen O
to O
thirty-five O
years O
old O
, O
or O
( O
2b O
) O
being O
diagnosed O
with O
asthma O
or O
chronic O
obstructive O
pulmonary O
disease O
( O
COPD O
) O
with O
an O
age O
greater O
than O
thirty O
years O
old O
. O

Exclusion O
criteria O
included O
diagnosis O
of O
neurological O
, O
mental O
or O
psychiatric O
illness O
and O
drug-resistant O
epilepsy O
. O

Three O
( O
3 O
) O
out O
of O
27 O
participants O
were O
young O
and O
unemployed O
adults O
, O
sixteen O
( O
16 O
) O
out O
of O
27 O
were O
asthma O
patients O
, O
and O
eight O
( O
8 O
) O
out O
of O
27 O
were O
COPD O
patients O
. O

The O
study O
( O
design O
, O
methodology O
, O
and O
experimental O
protocol O
) O
was O
approved O
by O
the O
Bioethics O
Committee O
of O
the O
Medical O
School O
of O
the O
Aristotle O
University O
of O
Thessaloniki O
. O

2.2 O
. O

Experimental O
Design O
Each O
participant O
went O
through O
a O
detailed O
clinical O
examination O
, O
which O
is O
a O
prerequisite O
for O
the O
SmokeFreeBrain O
( O
SFB O
) O
project O
( O
http O
: O
//smokefreebrain.eu/ O
) O
. O

Specifically O
, O
each O
participant O
, O
after O
checking O
for O
eligibility O
criteria O
, O
underwent O
a O
baseline O
clinical O
evaluation O
( O
session O
1 O
, O
Figure O
1 O
) O
prior O
to O
which O
eligibility O
criteria O
were O
tested O
. O

Session O
1 O
took O
place O
either O
at O
the O
private O
practice O
of O
a O
collaborator O
physician O
or O
at O
the O
Respiratory O
Failure O
Unit O
of O
“ O
G O
. O

Papanikolaou O
” O
General O
Hospital O
. O

If O
a O
participant O
was O
eligible O
, O
demographic O
, O
medical O
, O
and O
behavioral O
data O
were O
collected O
. O

Demographics O
included O
age O
, O
years O
of O
education O
, O
gender O
, O
body O
mass O
index O
( O
BMI O
) O
, O
number O
of O
cigarettes O
per O
day O
, O
and O
cigarette O
dependence O
in O
months O
. O

Clinical O
evaluation O
included O
pulmonary O
function O
tests O
such O
as O
spirometry O
with O
parameters O
of O
forced O
expiratory O
flow O
in O
1 O
second O
( O
FEV1 O
) O
, O
forced O
vital O
capacity O
( O
FVC O
) O
, O
expiratory O
ratio O
( O
% O
FEV1/FVC O
) O
, O
forced O
expiratory O
flow O
at O
the O
middle O
half O
of O
the O
FVC O
( O
FEF25–75 O
% O
) O
, O
and O
measurement O
of O
exhaled O
carbon O
monoxide O
levels O
( O
CO O
) O
, O
as O
well O
as O
a O
blood O
sampling O
for O
the O
evaluation O
of O
total O
oxidative O
stress/total O
oxidative O
capacity O
( O
TOS/TOC O
) O
, O
and O
vitamin O
E. O
In O
the O
current O
study O
, O
we O
just O
analyzed O
TOS/TOC O
scores O
both O
before O
and O
after O
the O
intervention O
. O

Behavioral O
assessment O
was O
performed O
by O
administrating O
a O
battery O
of O
behavioral O
tests O
and O
questionnaires O
validated O
or O
adapted O
for O
the O
Greek O
population O
. O

These O
were O
the O
following O
: O
Fagerström O
Test O
for O
Nicotine O
Dependence O
, O
Motivation O
, O
The O
Contemplation O
Ladder O
, O
Minnesota O
Nicotine O
Withdrawal O
Scale O
, O
Beck O
Depression O
Inventory O
, O
State-Trait O
Anxiety O
Inventory O
, O
General O
Health O
Test O
, O
Rosenberg O
Self-Esteem O
Scale O
, O
and O
World O
Health O
Organization O
Quality O
of O
Life O
Instrument—Brief O
. O

In O
addition O
, O
the O
COPD O
patients O
completed O
the O
COPD O
Assessment O
Test O
score O
and O
the O
COPD O
and O
Asthma O
Sleep O
Impact O
Scale O
, O
while O
asthma O
patients O
answered O
the O
Asthma O
Control O
Test O
. O

In O
session O
2 O
( O
Figure O
1 O
) O
, O
a O
baseline O
neuropsychological O
evaluation O
was O
performed O
administrating O
the O
Stroop O
Test O
, O
Trail-Making O
Test O
A O
and O
B O
, O
and O
Digit O
Span O
Test O
, O
along O
with O
an O
electrophysiological O
assessment O
through O
electroencephalographic O
recordings O
( O
EEG O
) O
in O
different O
conditions O
. O

EEG O
recordings O
were O
performed O
with O
a O
Nihon O
Kohden O
128-channel O
EEG O
recording O
system O
and O
an O
active O
electrode O
cap O
( O
actiCAP O
128Ch O
, O
Brain O
Products O
) O
according O
to O
the O
high-resolution O
EEG O
10-5 O
international O
electrode O
system O
. O

Recordings O
took O
place O
inside O
the O
electromagnetically O
shielded O
and O
sound-attenuated O
room O
of O
the O
Medical O
Physics O
Laboratory O
, O
before O
and O
after O
the O
biofeedback O
training O
. O

They O
were O
performed O
at O
a O
sampling O
rate O
of O
1000 O
Hz O
, O
while O
electrode O
impedances O
of O
the O
brain O
signal O
, O
ground O
electrode O
, O
and O
references O
were O
kept O
lower O
than O
10 O
kΩ O
. O

EEG O
was O
recorded O
during O
four O
different O
conditions O
, O
including O
eyes O
open O
( O
EO O
) O
( O
5 O
minutes O
) O
, O
eyes O
fixated O
in O
a O
smoking-related O
image O
( O
EF O
) O
( O
1 O
minute O
) O
, O
eyes O
closed O
( O
EC O
) O
( O
5 O
minutes O
) O
, O
and O
a O
multifeature O
auditory O
mismatch O
negativity O
measurement O
according O
to O
the O
guidelines O
of O
Näätänen O
et O
al O
. O

( O
15 O
min O
in O
duration O
) O
. O

In O
the O
current O
manuscript O
, O
eyes-closed O
data O
were O
analyzed O
following O
the O
suggestions O
by O
Raichle O
et O
al. O
, O
where O
resting-state O
is O
defined O
as O
a O
task-free O
state O
in O
which O
the O
individuals O
rest O
quietly O
awake O
with O
eyes O
closed O
. O

The O
intervention O
phase O
( O
Figure O
1 O
) O
consisted O
of O
five O
30-minute O
sessions O
of O
skin O
temperature O
training O
. O

Each O
training O
session O
included O
, O
at O
the O
start O
, O
an O
introduction O
to O
stress-coping O
techniques O
of O
15-minute O
length O
and O
a O
one-minute O
baseline O
peripheral O
temperature O
recording O
. O

These O
were O
followed O
by O
30 O
minutes O
of O
skin O
temperature O
training O
as O
suggested O
by O
Peniston O
and O
Kulkosky O
. O

Participants O
sat O
comfortably O
on O
a O
reclined O
chair O
across O
a O
computer O
monitor O
resting O
their O
nondominant O
hand O
on O
the O
lap O
or O
a O
pillow O
. O

A O
sensitive O
thermistor O
was O
placed O
in O
the O
middle O
fingertip O
of O
their O
nondominant O
hand O
. O

The O
training O
goal O
at O
each O
session O
was O
to O
achieve O
temperature O
enhancement O
while O
receiving O
an O
audiovisual O
feedback O
. O

When O
the O
temperature O
exceeded O
an O
autoadjusted O
threshold O
, O
a O
puzzle O
was O
being O
formed O
accompanied O
by O
a O
pleasant O
auditory O
stimulus O
as O
described O
in O
. O

In O
the O
posttraining O
phase O
( O
sessions O
3 O
and O
4 O
) O
, O
the O
followed O
procedures O
were O
identical O
to O
the O
baseline O
. O

Additionally O
, O
in O
the O
posttraining O
clinical O
evaluation O
, O
urine O
samples O
were O
collected O
to O
assess O
cotinine O
levels O
in O
our O
participants O
apart O
from O
the O
procedures O
already O
described O
for O
the O
baseline O
screening O
. O

In O
later O
phases O
of O
the O
intervention O
, O
as O
part O
of O
the O
SmokeFreeBrain O
project O
, O
multiple O
sessions O
of O
alpha-theta O
neurofeedback O
training O
are O
introduced O
, O
but O
this O
is O
not O
discussed O
in O
the O
current O
study O
. O

2.3 O
. O

Total O
Oxidative O
Capacity/Total O
Oxidative O
Stress O
( O
TOC/TOS O
) O
After O
blood O
draw O
, O
blood O
samples O
were O
centrifuged O
for O
10 O
min O
at O
2000g O
and O
4°C O
, O
and O
serum O
samples O
( O
1 O
ml O
) O
, O
divided O
in O
two O
or O
three O
microcentrifuge O
tubes O
, O
were O
stored O
at O
−80°C O
. O

The O
average O
time O
lapse O
between O
sample O
collection O
and O
freezing O
was O
90 O
minutes O
. O

Determination O
of O
the O
peroxides O
was O
performed O
by O
the O
reaction O
of O
a O
peroxidase O
with O
peroxides O
in O
the O
sample O
followed O
by O
the O
conversion O
of O
tetramethyl O
benzidine O
to O
a O
colored O
product O
. O

After O
the O
addition O
of O
a O
stop O
solution O
, O
the O
samples O
were O
measured O
at O
450 O
nm O
in O
a O
microliter O
plate O
reader O
. O

The O
quantification O
was O
performed O
by O
the O
delivered O
calibrator O
. O

2.4 O
. O

Data O
Preprocessing O
and O
Resting-State O
Connectivity O
The O
Brain O
Electrical O
Source O
Analysis O
software O
( O
BESA O
research O
, O
version O
6.0 O
, O
Megis O
Software O
, O
Heidelberg O
, O
Germany O
) O
was O
used O
for O
the O
preprocessing O
of O
the O
EEG O
data O
in O
EC O
condition O
. O

Data O
were O
visually O
inspected O
to O
detect O
bad O
channels O
. O

Bad O
channels O
detected O
along O
with O
ground O
and O
reference O
electrodes O
( O
AFz O
and O
FCz O
, O
resp O
. O
) O

were O
interpolated O
via O
an O
interpolation O
algorithm O
of O
the O
BESA O
software O
. O

A O
high-pass O
filter O
with O
a O
cutoff O
frequency O
at O
1 O
Hz O
was O
chosen O
to O
remove O
low-frequency O
signals O
along O
with O
a O
low-pass O
filter O
with O
a O
cutoff O
frequency O
at O
30 O
Hz O
removing O
high-frequency O
signals O
. O

Furthermore O
, O
a O
notch O
filter O
was O
used O
at O
50 O
Hz O
in O
order O
to O
eliminate O
the O
industrial O
noise O
. O

Independent O
component O
analysis O
( O
ICA O
) O
decomposition O
was O
performed O
in O
the O
current O
screen O
of O
the O
EEG O
data O
( O
60 O
seconds O
) O
using O
the O
principal O
component O
analysis O
( O
PCA O
) O
technique O
. O

In O
more O
detail O
, O
the O
method O
underlying O
the O
ICA O
analysis O
is O
the O
extended O
ICA O
algorithm O
. O

The O
dimensionality O
of O
data O
was O
reduced O
by O
PCA O
before O
ICA O
by O
ignoring O
all O
PCA O
components O
that O
explain O
less O
than O
1 O
% O
of O
the O
variance O
. O

Linear O
drifts O
, O
heart O
modulation O
, O
muscle O
contamination O
, O
artifacts O
induced O
by O
the O
participant O
's O
movements O
, O
and O
high-frequency O
noise O
were O
characterized O
as O
artifactual O
sources O
and O
removed O
. O

After O
reconstructing O
the O
whole O
dataset O
excluding O
noisy O
ICA O
components O
, O
data O
were O
visually O
inspected O
. O

Ten O
random O
epochs O
of O
equal O
length O
( O
4 O
seconds O
) O
were O
extracted O
using O
ten O
random O
triggers O
and O
exporting O
an O
interval O
of O
4000 O
ms O
around O
the O
triggers O
( O
−2000 O
ms O
to O
+2000 O
ms O
) O
. O

An O
equal O
number O
of O
epochs O
( O
epochs O
= O
10 O
) O
was O
exported O
for O
both O
baseline O
and O
posttraining O
EEG O
recordings O
( O
EC O
) O
. O

Afterwards O
, O
the O
lead O
field O
matrix O
was O
obtained O
by O
the O
eConnectome O
toolbox O
relating O
2054 O
scalp O
triangles O
to O
7850 O
cortical O
dipoles O
. O

The O
lead O
field O
matrix O
is O
provided O
by O
means O
of O
a O
three-layer O
BEM O
model O
based O
on O
the O
Colin27 O
MNI O
brain O
. O

The O
dipoles O
were O
restricted O
to O
the O
gray O
matter O
with O
perpendicular O
orientations O
towards O
the O
local O
cortical O
surface O
. O

Minimum O
norm O
estimate O
( O
MNE O
) O
was O
performed O
to O
solve O
the O
inverse O
problem O
by O
minimizing O
the O
source O
space O
energy O
given O
that O
the O
source O
dipoles O
' O
power O
is O
constrained O
by O
the O
cortex O
physiology O
. O

Tikhonov O
regularization O
was O
applied O
through O
the O
Regularization O
Toolbox O
to O
find O
the O
MNE O
solution O
. O

Additionally O
, O
we O
created O
eighteen O
custom-defined O
ROIs O
representing O
important O
nodes O
of O
the O
default O
mode O
network O
( O
DMN O
) O
at O
the O
surface O
of O
the O
cortex O
cortical O
model O
, O
in O
order O
to O
proceed O
to O
the O
computation O
of O
connectivity O
( O
Figure O
2 O
) O
. O

The O
ROI O
time O
series O
signal O
was O
computed O
by O
averaging O
the O
signal O
of O
all O
included O
cortical O
current O
dipoles O
. O

ROI O
time O
series O
were O
computed O
for O
each O
node O
at O
each O
of O
the O
ten O
4-second O
epochs O
for O
each O
subject O
. O

The O
functional O
cortical O
connectivity O
between O
the O
18 O
custom-defined O
nodes O
of O
DMN O
was O
evaluated O
by O
means O
of O
the O
directed O
transfer O
function O
( O
DTF O
) O
metric O
with O
significance O
testing O
using O
surrogate O
data O
. O

DTF O
is O
a O
Granger O
causality O
measure O
that O
uses O
the O
multivariate O
autoregressive O
model O
( O
MVAR O
) O
and O
describes O
the O
information O
flow O
between O
the O
node O
j O
and O
the O
node O
i O
at O
frequency O
f O
, O
producing O
weighted O
directed O
graphs O
. O

The O
order O
of O
the O
MVAR O
model O
was O
set O
to O
ten O
, O
based O
on O
SBC O
and O
FPE O
criteria O
as O
computed O
by O
the O
eConnectome O
software O
. O

For O
our O
analysis O
, O
DTF O
networks O
were O
computed O
at O
the O
frequency O
band O
of O
alpha O
rhythm O
at O
8–12 O
Hz O
as O
alpha O
rhythm O
is O
the O
dominant O
brain O
rhythm O
at O
idling O
rest O
. O

DTF O
was O
computed O
between O
ROI O
time O
series O
of O
the O
network O
nodes O
at O
each O
of O
the O
ten O
4-second O
epochs O
for O
each O
subject O
, O
producing O
27∗10∗2 O
adjacency O
matrices O
( O
for O
the O
pre- O
and O
posttime O
conditions O
) O
. O

The O
DTF O
adjacency O
matrices O
, O
corresponding O
to O
resting-state O
connectivity O
networks O
, O
were O
then O
compared O
between O
pre- O
and O
posttime O
conditions O
, O
in O
order O
to O
identify O
significantly O
altered O
connections O
. O

For O
this O
, O
we O
tested O
by O
false O
discovery O
rate O
( O
FDR O
) O
with O
5000 O
permutations O
, O
using O
the O
NBS O
toolbox O
. O

Following O
the O
aforementioned O
analysis O
design O
, O
we O
further O
explored O
possible O
differences O
in O
resting-state O
networks O
depending O
on O
gender O
. O

2.5 O
. O

Network O
Analysis O
Network O
analysis O
was O
performed O
using O
the O
Brain O
Connectivity O
Toolbox O
( O
BCT O
) O
for O
alpha O
band O
networks O
. O

The O
topological O
properties O
of O
the O
connectivity O
adjacency O
matrices O
were O
calculated O
using O
graph O
network O
analysis O
at O
each O
epoch O
for O
each O
subject O
. O

The O
topological O
properties O
were O
then O
averaged O
across O
epochs O
for O
each O
subject O
, O
producing O
two O
average O
values O
of O
each O
property O
( O
detailed O
below O
) O
for O
the O
resting-state O
network O
of O
each O
subject O
, O
one O
at O
the O
pre- O
and O
one O
at O
the O
posttime O
condition O
. O

Characteristic O
path O
length O
( O
CPL O
) O
, O
mean O
clustering O
coefficient O
( O
CC O
) O
, O
and O
density O
( O
D O
) O
, O
as O
well O
as O
the O
small-world O
( O
SW O
) O
measures O
were O
computed O
. O

Moreover O
, O
the O
in- O
and O
out-strengths O
values O
for O
each O
of O
the O
18 O
nodes O
of O
the O
network O
were O
also O
calculated O
. O

Characteristic O
path O
length O
( O
CPL O
) O
is O
the O
average O
shortest O
distance O
between O
node O
i O
and O
all O
other O
nodes O
, O
and O
it O
is O
considered O
as O
measure O
of O
integration O
. O

Mean O
clustering O
coefficient O
( O
CC O
) O
, O
a O
measure O
of O
segregation O
, O
indicates O
the O
graph O
nodes O
' O
tendency O
to O
be O
organized O
in O
triangles O
. O

Density O
( O
D O
) O
is O
the O
number O
of O
actual O
connections O
among O
network O
nodes O
divided O
by O
the O
maximum O
possible O
connections O
. O

Small-world O
( O
SW O
) O
networks O
( O
small-world O
scalar O
is O
defined O
in O
) O
are O
characterized O
by O
a O
short O
path O
length O
that O
is O
indicative O
of O
communication O
efficiency O
along O
with O
a O
high O
clustering O
coefficient O
which O
represents O
a O
high O
suborganization O
. O

In O
our O
study O
, O
the O
comparison O
of O
CPL O
and O
CC O
in O
the O
SW O
metric O
was O
made O
against O
10,000 O
random O
networks O
with O
the O
same O
number O
of O
connections O
and O
density O
to O
connectivity O
networks O
. O

The O
in-strength O
metric O
for O
each O
node O
( O
IS O
) O
was O
defined O
as O
the O
sum O
of O
the O
weights O
of O
all O
incoming O
connections O
to O
that O
node O
. O

The O
out-strength O
metric O
for O
each O
node O
( O
OS O
) O
was O
calculated O
by O
adding O
the O
weights O
of O
outgoing O
connections O
from O
that O
node O
. O

2.6 O
. O

Statistical O
Analysis O
All O
statistical O
analyses O
were O
performed O
using O
the O
IBM O
SPSS O
( O
version O
23 O
) O
and O
the O
level O
at O
which O
the O
null O
hypothesis O
is O
rejected O
was O
set O
as O
5 O
out O
of O
100 O
( O
a O
= O
0.05 O
) O
. O

2.6.1 O
. O

Demographic O
Data O
Demographic O
data O
were O
tested O
for O
normality O
assumption O
by O
visual O
inspection O
of O
histograms O
, O
normal O
Q-Q O
plots O
, O
and O
boxplots O
, O
checking O
skewness O
and O
kurtosis O
parameters O
, O
and O
using O
formal O
normality O
tests O
( O
Shapiro-Wilk O
test O
and O
Kolmogorov-Smirnov O
test O
) O
in O
order O
to O
calculate O
the O
appropriate O
measures O
of O
centrality O
and O
variation O
. O

As O
the O
variables O
age O
, O
education O
years O
, O
BMI O
index O
, O
and O
smoking O
dependence O
in O
months O
were O
approximately O
normally O
distributed O
, O
mean O
and O
standard O
deviation O
were O
calculated O
while O
median O
and O
interquartile O
range O
were O
calculated O
for O
the O
number O
of O
daily O
cigarettes O
. O

Moreover O
, O
we O
investigated O
gender O
differences O
in O
demographic O
data O
. O

Normality O
assumption O
was O
tested O
for O
demographics O
between O
male O
and O
female O
participants O
. O

Depending O
on O
the O
normality O
assumption O
, O
either O
t-test O
for O
independent O
samples O
or O
the O
Mann–Whitney O
U O
test O
was O
performed O
. O

2.6.2 O
. O

Clinical O
Data O
Total O
oxidative O
stress/total O
oxidative O
capacity O
( O
TOS/TOC O
) O
was O
analyzed O
at O
the O
two O
time O
conditions O
in O
the O
twenty-two O
participants O
out O
of O
twenty-seven O
as O
the O
rest O
of O
the O
samples O
were O
not O
available O
. O

Differences O
in O
oxidative O
stress O
were O
initially O
explored O
using O
paired O
t-test O
, O
as O
they O
were O
continuous O
variables O
and O
approximately O
normally O
distributed O
. O

Exhaled O
CO O
levels O
were O
also O
compared O
both O
before O
and O
after O
biofeedback O
training O
using O
paired O
t-test O
. O

Additionally O
, O
we O
explored O
gender O
differences O
in O
clinical O
data O
. O

Using O
repeated O
measures O
analysis O
of O
variance O
, O
with O
gender O
as O
a O
covariate O
factor O
, O
could O
be O
an O
analysis O
of O
choice O
, O
but O
this O
was O
not O
followed O
because O
normality O
assumption O
was O
not O
met O
in O
every O
cell O
of O
the O
analysis O
. O

Thus O
, O
within-group O
changes O
in O
TOS O
and O
CO O
levels O
, O
respectively O
, O
were O
explored O
using O
the O
Wilcoxon O
Signed O
Ranks O
test O
or O
paired O
t-test O
after O
grouping O
by O
gender O
. O

Between-group O
differences O
of O
clinical O
data O
at O
the O
two O
time O
points O
were O
compared O
between O
male O
and O
female O
cohorts O
using O
the O
Mann–Whitney O
U O
test O
or O
independent O
samples O
t-test O
. O

2.6.3 O
. O

Behavioral O
Data O
Total O
scores O
collected O
by O
neuropsychological O
tests O
and O
questionnaires O
such O
as O
the O
Fagerström O
Test O
, O
Minnesota O
Nicotine O
Withdrawal O
Scale O
, O
Beck O
Depression O
Inventory O
II O
( O
BDI O
II O
) O
, O
State-Trait O
Anxiety O
Inventory O
I O
( O
STAI O
I O
) O
and O
II O
( O
STAI O
II O
) O
, O
General O
Health O
Test O
, O
Rosenberg O
Self-Esteem O
Scale O
, O
and O
Motivation O
test O
were O
analyzed O
in O
this O
study O
. O

More O
precisely O
, O
score O
differences O
both O
before O
and O
after O
biofeedback O
training O
were O
calculated O
for O
each O
test O
or O
questionnaire O
. O

Score O
differences O
were O
tested O
for O
normality O
assumption O
using O
the O
aforementioned O
methodology O
( O
Section O
2.6.1 O
) O
. O

Depending O
on O
normality O
assumption O
, O
different O
analyses O
were O
planned O
( O
paired O
t-tests O
or O
Wilcoxon O
Signed O
Ranks O
tests O
) O
. O

However O
, O
total O
scores O
of O
Fagerström O
Test O
at O
the O
two O
time O
points O
were O
also O
converted O
into O
ordinal O
variables O
using O
the O
following O
formula O
: O
( O
a O
) O
scores O
from O
0 O
to O
3 O
were O
coded O
as O
low O
dependent O
, O
( O
b O
) O
scores O
from O
4 O
to O
6 O
were O
coded O
as O
medium O
dependent O
, O
and O
( O
c O
) O
scores O
from O
7 O
to O
10 O
were O
coded O
as O
high O
dependent O
. O

In O
this O
case O
, O
differences O
between O
different O
levels O
of O
dependence O
at O
the O
two O
time O
points O
were O
investigated O
performing O
the O
McNemar-Bowker O
Test O
. O

In O
the O
case O
where O
differences O
between O
different O
levels O
of O
dependence O
reached O
statistical O
significance O
( O
p O
values O
< O
0.05 O
) O
, O
McNemar O
tests O
were O
performed O
by O
two O
. O

In O
this O
case O
, O
p O
values O
were O
corrected O
for O
multiple O
comparisons O
using O
Bonferroni O
correction O
. O

Gender O
differences O
were O
further O
explored O
in O
behavioral O
data O
. O

As O
data O
did O
not O
fit O
in O
the O
assumptions O
of O
repeated-measures O
ANOVA O
with O
a O
covariate O
, O
an O
alternative O
design O
was O
preferred O
. O

Score O
differences O
in O
neuropsychological O
tests O
and O
questionnaires O
were O
calculated O
and O
then O
tested O
for O
normality O
assumption O
between O
male O
and O
female O
participants O
. O

Depending O
on O
the O
normality O
assumption O
of O
score O
differences O
, O
within-group O
comparisons O
were O
performed O
using O
either O
paired O
t-test O
or O
the O
Wilcoxon O
Signed O
Ranks O
test O
after O
grouping O
data O
by O
gender O
. O

Independent O
samples O
t-test O
or O
the O
Mann–Whitney O
U O
tests O
were O
run O
for O
between-group O
comparisons O
. O

2.6.4 O
. O

Network O
Properties O
Network O
properties O
such O
as O
CPL O
, O
mean O
CC O
, O
D O
, O
and O
SW O
, O
as O
well O
as O
IS O
and O
OS O
were O
calculated O
for O
each O
participant O
at O
the O
two O
time O
points O
. O

Differences O
( O
posttraining O
values O
− O
pretraining O
values O
) O
were O
computed O
for O
each O
property O
at O
the O
two O
time O
conditions O
and O
then O
tested O
for O
normality O
assumption O
. O

Different O
analyses O
were O
performed O
, O
either O
paired O
t-tests O
or O
the O
Wilcoxon O
Signed O
Ranks O
tests O
, O
at O
each O
network O
property O
depending O
on O
normality O
assumption O
. O

Possible O
within- O
and O
between-group O
differences O
depending O
on O
gender O
were O
explored O
using O
the O
same O
methodology O
as O
the O
one O
used O
in O
clinical O
and O
behavioral O
data O
. O

